VE-303
PureTech Health
[]
vedanta biosciences receives fast track designation for ve303 and presents phase 2 data at digestive disease week #cdiff #cdi 
Dave is a public health advocate who has spent 10 years studying C. Difficile. This account is updated daily and highlights media and journal sources.